A new drug is delivering remarkable results for Multiple Sclerosis sufferers

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

ST. LOUIS, MO (KPLR) -   A promising treatment for Multiple Sclerosis once banned in the United States has now been approved. The FDA decided to give the green light to the drug Lemtrada.The drug is a disease-modifying therapy for people with relapsing forms of MS. It is given as intravenous infusions.

Many people who suffer from MS in the United States are upset with the FDA for taking so long to approve Lemtrada.  Patients who had exhausted other treatment options filed a petition to fight the ruling not to approve the drug last year.

Lemtrada is already being used in more than 40 countries, including European Union nations, Canada, Mexico, Australia, and South Korea.

What is MS?


Notice: you are using an outdated browser. Microsoft does not recommend using IE as your default browser. Some features on this website, like video and images, might not work properly. For the best experience, please upgrade your browser.